Home/Pipeline/New Model Development

New Model Development

Potential new organ systems

N/AActive

Key Facts

Indication
Potential new organ systems
Phase
N/A
Status
Active
Company

About SynVivo

SynVivo is a private company, founded in 2009 and headquartered in Huntsville, Alabama, that has established itself as a leader in the organ-on-a-chip (OoC) sector. It commercializes a portfolio of validated, ready-to-use microfluidic platforms (e.g., SynBBB, SynTumor, SynRAM) that mimic vascularized human tissue for predictive preclinical testing. Its business model combines product sales (chips, instruments, accessories) with fee-for-service offerings in screening and assay development, positioning it as a critical tools and services provider enabling the pharmaceutical industry's shift towards New Approach Methodologies (NAMs). The company is in a revenue-generating stage, serving academic, biotech, and pharma researchers.

View full company profile